{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fidpodcast.simplecast.com%2Fepisodes%2Fla-art-system-considerations-A5GInF2p","width":444,"version":"1.0","type":"rich","title":"Implementing Long-Acting Cabotegravir Plus Rilpivirine for HIV Treatment: System-Level Considerations","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/26d7523c-7315-48a0-9da6-29d252d3ce90/3338da17-cc11-465b-bbcb-27acbb133654/pod459-post-croi-virtual-viiv-sympo-podcast-02.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/faa764f9-8cf5-4c90-a4d7-a42c89777de5\" height=\"200\" width=\"100%\" title=\"Implementing Long-Acting Cabotegravir Plus Rilpivirine for HIV Treatment: System-Level Considerations\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"This podcast episode features an international panel discussion on clinic-level considerations for incorporating long-acting ART into the HIV treatment paradigm. "}